+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sufentanil"

From
From
United States DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States DSUVIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DSUVIA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Sufentanil is an analgesic drug used to treat moderate to severe pain. It is a synthetic opioid, similar to fentanyl, and is administered intravenously or intramuscularly. It is often used in the operating room for general anesthesia and in the intensive care unit for pain management. It is also used in the emergency department for pain relief in trauma patients. Sufentanil is a powerful opioid, and its use is associated with a risk of addiction, abuse, and misuse. Sufentanil is available in a variety of formulations, including tablets, capsules, and injectable solutions. It is also available in combination with other analgesics, such as acetaminophen and ibuprofen. Sufentanil is typically prescribed for short-term use, and its effects can last up to four hours. The Sufentanil market is highly competitive, with many companies offering different formulations and combinations of the drug. Some of the major players in the market include Mylan, Pfizer, Teva Pharmaceuticals, and Endo Pharmaceuticals. Show Less Read more